If you have difficulty in submitting comments on draft standards you can use a commenting template and email it to admin.start@bsigroup.com. The commenting template can be found here.

We use cookies to give you the best experience and to help improve our website

Find out what cookies we use and how to disable them

BS EN ISO 11616 Health informatics — Identification of medicinal products — Data elements and structures for unique identification and exchange of regulated pharmaceutical product information

Source:
ISO
Committee:
IST/35 - Health informatics
Categories:
IT applications. Health care technology
Comment period start date:
Comment period end date:
Number of comments:
0

Comment by:

Scope

This document is intended to provide specific levels of information relevant to the identification of a Pharmaceutical Product or groups of Pharmaceutical Products. It defines the data elements, structures and relationships between data elements that are required for the exchange of regulated information, in order to uniquely identify pharmaceutical products. This identification is to be applied throughout the product lifecycle to support pharmacovigilance, regulatory and other activities worldwide. In addition, this document is essential to ensure that pharmaceutical product information is assembled in a structured format with transmission between a diverse set of stakeholders for both regulatory and clinical (e.g. e-prescribing, clinical decision support) purposes. This ensures interoperability and compatibility for both the sender and the recipient.

This document is not intended to be a scientific classification for pharmaceutical products. Rather, it is a formal association of particular data elements categorised in prescribed combinations and uniquely identified when levelling degrees of information are incomplete. This allows for Pharmaceutical Products to be unequivocally identified on a global level.

References to other normative IDMP standards and specifications for data exchange mechanisms for pharmaceutical product information are included in Clause 2, to be applied in the context of this document.

Medicinal products for veterinary use are out of scope of this document.

Read draft and comment

Comment on proposal

Required form fields are indicated by an asterisk (*) character.


Please email further comments to: debbie.stead@bsigroup.com

Follow standard

You are now following this standard. Weekly digest emails will be sent to update you on the following activities:

You can manage your follow preferences from your Account. Please check your mailbox junk folder if you don't receive the weekly email.

Unfollow standard

You have successfully unsubscribed from weekly updates for this standard.

Error